Abstract:Background: Delivery systems based on albumin nanoparticles (NPs) have recently garnered substantial interest in anti-tumor drug development. However, systematic bibliometric analyses in this field remain lacking. This study aimed to analyze the current research status, hotspots, and frontiers in the application of albumin NPs in the field of oncology from a bibliometric perspective. Methods: Using the Web of Science Core Collection (WOSCC) as the data source, retrieved articles were analyzed using software, such as VOSviewer 1.6.18 and CiteSpace 6.1.6, and the relevant visualization maps were plotted. Results: From 1 January 2000, to 15 April 2024, 2,262 institutions from 67 countries/regions published 1,624 articles related to the application of albumin NPs in the field of oncology. The USA was a leader in this field and held a formidable academic reputation. The most productive institution was the Chinese Academy of Sciences. The most productive author was Youn YS, whereas Kratz F was the most frequently co-cited author. The most productive journal was the International Journal of Nanomedicine , whereas the Journal of Controlled Release was the most co-cited journal. Future research hotspots and frontiers included "rapid and convenient synthesis methods predominated by self-assembly," "surface modification," "construction of multifunctional NPs for theranostics," "research on natural active ingredients mainly based on phenolic compounds," "combination therapy," and "clinical applications." Conclusion: Based on our bibliometric analysis and summary, we obtained an overview of the research on albumin NPs in the field of oncology, identified the most influential countries, institutions, authors, journals, and citations, and discussed the current research hotspots and frontiers in this field. Our study may serve as an important reference for future research in this field.

Application of Albumin in Nanodrugs for Cancer Therapy

Preparation of Drug-Loaded Albumin Nanoparticles and Its Application in Cancer Therapy

Protein Nanoparticles Directed Cancer Imaging and Therapy

Bovine Serum Albumin as a Versatile Platform for Cancer Imaging and Therapy

Recent Advancements in Serum Albumin-Based Nanovehicles Toward Potential Cancer Diagnosis and Therapy

Albumin nanoscience: homing nanotechnology enabling targeted drug delivery and therapy

Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery

Albumin Nanoparticle Encapsulation of Potent Cytotoxic Therapeutics Shows Sustained Drug Release and Alleviates Cancer Drug Toxicity.

Albumin-based nanodevices for breast cancer diagnosis and therapy

The Neoteric Paradigm of Biomolecule-Functionalized Albumin-Based Targeted Cancer Therapeutics

Revolutionizing breast cancer treatment: Harnessing the potential of albumin nanoparticles as targeted drug delivery vehicles

Albumin Nanoparticles in Cancer Therapeutics: Clinical Status, Challenges, and Future Directions

Harnessing albumin as a carrier for cancer therapies

Strategies for Preparing Albumin-based Nanoparticles for Multifunctional Bioimaging and Drug Delivery

Albumin-binding Prodrugs Via Reversible Iminoboronate Forming Nanoparticles for Cancer Drug Delivery.

Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation

Hyaluronic acid and albumin based nanoparticles for drug delivery

Trend of albumin nanoparticles in oncology: a bibliometric analysis of research progress and prospects

Protein nanoparticles in drug delivery: animal protein, plant proteins and protein cages, albumin nanoparticles

Gold Nanoparticles: Construction for Drug Delivery and Application in Cancer Immunotherapy

Nanomaterials in Cancer-Therapy Drug Delivery System